Trials / Completed
CompletedNCT02897817
Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis
Treatment Adherence in Patients With Rheumatoid Arthritis Previously Treated With Oral or Injectable Methotrexate and Requiring a New Treatment With Injectable Methotrexate
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 471 (actual)
- Sponsor
- Nordic Pharma SAS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate, at 6 months, the rate of patients whose adherence to injectable MTX remained strong or improved according to patient-reported outcome.
Conditions
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2016-09-13
- Last updated
- 2018-03-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02897817. Inclusion in this directory is not an endorsement.